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Background: B-type natriuretic peptide (BNP) is a biomarker produced by ventricular myocardium. N-terminal pro-natriuretic peptide (pro-BNP) is 
the precursor to BNP and a more stable assay. In adults, BNP is used as an indicator of rejection or dysfunction and thought to correlate with clinical 
heart failure. At Children’s Hospital of Wisconsin, BNP is used in evaluation of transplant or heart failure patients. Due to a paucity of literature on 
the subject, this study aims to determine if pro-BNP correlates with BNP in children.
Methods: Pediatric heart transplant or heart failure patients requiring BNP testing were recruited. 146 samples were drawn from 51 patients 
(mean age 9.6 years). Pro-BNP and BNP levels were run from the same sample. The Pediatric Heart Failure Index (PHFI) was applied for each patient. 
Serum creatinine and echo data were also obtained as per routine. Due to the dependent structure of the data, we employed the bootstrap method 
to obtain the correlation coefficient and its 95% confidence interval.
Results: There is a strong correlation between BNP and pro-BNP. Both markers correlate well with heart failure index but not with ventricular 
function by echo. Renal function did not independently correlate with either biomarker.
Correlation - BNP and Pro-BNP
Correlation 95% Confidence Interval
BNP vs. pro- BNP 0.63 (0.588, 0.761)
BNP vs. Cr 0.233 (0.163, 0.341)
pro-BNP vs. Cr 0.536 (0.375, 0.715)
BNP vs. ECHO EF -0.214 (-0.597, 0.158)
pro-BNP vs. ECHO EF -0.076 (-0.341, 0.094)
BNP vs. PHFI 0.430 (0.360, 0.513)
pro-BNP vs. PHFI 0.413 (0.214, 0.523)
Conclusion: BNP and pro-BNP may be equivalent as biomarkers for heart failure in children. Larger series are required to characterize the utility of 
pro-BNP specifically in the transplant population or in the face of renal dysfunction.
